DOI QR코드

DOI QR Code

Characteristics, Outcomes and Predictors of Long-Term Mortality for Patients Hospitalized for Acute Heart Failure: A Report From the Korean Heart Failure Registry

  • Choi, Dong-Ju (Department of Internal Medicine, Seoul National University College of Medicine, Bundang Hospital) ;
  • Han, Seong-Woo (Department Internal Medicine, Korea University College of Medicine) ;
  • Jeon, Eun-Seok (Department of Internal Medicine, Sungkyunkwan University College of Medicine, Samsung Medical Center) ;
  • Cho, Myeong-Chan (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Kim, Jae-Joong (Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Yoo, Byung-Su (Department of Internal Medicine, Yonsei University Wonju Christian Hospital) ;
  • Shin, Mi-Seung (Department of Internal Medicine, Gachon University Gil Hospital) ;
  • Seong, In-Whan (Department of Internal Medicine, Chungnam National University College of Medicine) ;
  • Ahn, Young-Keun (Department of Internal Medicine, Chonnam National University College of Medicine) ;
  • Kang, Seok-Min (Department of Internal Medicine, Yonsei University Severance Hospital) ;
  • Kim, Yung-Jo (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Kim, Hyung-Seop (Department of Internal Medicine, Keimyung University College of Medicine) ;
  • Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University College of Medicine) ;
  • Oh, Byung-Hee (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Lee, Myung-Mook (Department of Internal Medicine, Dongguk University College of Medicine, Ilsan Hospital) ;
  • Ryu, Kyu-Hyung (Department of Internal Medicine, Konkuk University Medical Center) ;
  • The KorHF Registry, The KorHF Registry (The KorHF Registry)
  • Published : 2011.07.30

Abstract

Background and Objectives: Acute heart failure (AHF) is associated with a poor prognosis and it requires repeated hospitalizations. However, there are few studies on the characteristics, treatment and prognostic factors of AHF. The aims of this study were to describe the clinical characteristics, management and outcomes of the patients hospitalized for AHF in Korea. Subjects and Methods: We analyzed the clinical data of 3,200 hospitalization episodes that were recorded between June 2004 and April 2009 from the Korean Heart Failure (KorHF) Registry database. The mean age was 67.6${\pm}$14.3 years and 50% of the patients were female. Results: Twenty-nine point six percent (29.6%) of the patients had a history of previous HF and 52.3% of the patients had ischemic heart disease. Left ventricular ejection fraction (LVEF) was reported for 89% of the patients. The mean LVEF was 38.5${\pm}$15.7% and 26.1% of the patients had preserved systolic function (LVEF ${\geq}$50%), which was more prevalent in the females (34.0% vs. 18.4%, respectively, p<0.001). At discharge, 58.6% of the patients received beta-blockers (BB), 53.7% received either angiotensin converting enzyme-inhibitors or angiotensin receptor blockers (ACEi/ARB), and 58.4% received both BB and ACEi/ARB. The 1-, 2-, 3- and 4-year mortality rates were 15%, 21%, 26% and 30%, respectively. Multivariate analysis revealed that advanced age {hazard ratio: 1.023 (95% confidence interval: 1.004-1.042); p=0.020}, a previous history of heart failure {1.735 (1.150-2.618); p=0.009}, anemia {1.973 (1.271-3.063); p=0.002}, hyponatremia {1.861 (1.184-2.926); p= 0.007}, a high level of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) {3.152 (1.450-6.849); p=0.004} and the use of BB at discharge {0.599 (0.360-0.997); p=0.490} were significantly associated with total death. Conclusion: We present here the characteristics and prognosis of an unselected population of AHF patients in Korea. The long-term mortality rate was comparable to that reported in other countries. The independent clinical risk factors included age, a previous history of heart failure, anemia, hyponatremia, a high NT-proBNP level and taking BB at discharge.

Keywords

References

  1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18. https://doi.org/10.1056/NEJMra021498
  2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347: 1397-402. https://doi.org/10.1056/NEJMoa020265
  3. Studies of left ventricular dysfunction (SOLVD): rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 1990;66:315-22. https://doi.org/10.1016/0002-9149(90)90842-O
  4. Franciosa JA, Abraham WT, Fowler M, et al. Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE): COHERE Participant Physicians. J Card Fail 2000;6:264-71. https://doi.org/10.1054/jcaf.2000.9675
  5. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27:65-75. https://doi.org/10.1093/eurheartj/ehi555
  6. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442. https://doi.org/10.1093/eurheartj/ehn309
  7. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15. https://doi.org/10.1161/01.CIR.88.1.107
  8. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam Study. Eur Heart J 2001;22: 1318-27. https://doi.org/10.1053/euhj.2000.2533
  9. Kawashiro N, Kasanuki H, Ogawa H, Matsuda N, Hagiwara N. Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry. Circ J 2008;72:2015-20. https://doi.org/10.1253/circj.CJ-08-0323
  10. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-8. https://doi.org/10.1016/j.ahj.2007.03.012
  11. Fonarow GC, Corday E. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev 2004;9:179-85.
  12. Echols MR, Felker GM, Thomas KL, et al. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial. J Card Fail 2006;12:684-8. https://doi.org/10.1016/j.cardfail.2006.08.003
  13. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12. https://doi.org/10.1016/S0002-8703(97)70173-X
  14. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16. https://doi.org/10.1016/j.ahj.2004.08.005
  15. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe: part 2: treatment. Eur Heart J 2003;24:464-74. https://doi.org/10.1016/S0195-668X(02)00700-5
  16. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme: a survey on the quality of care among patients with heart failure in Europe: part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
  17. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13: 1928-36. https://doi.org/10.1097/01.ASN.0000018409.45834.FA
  18. Rudiger A, Harjola VP, Müller A, et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 2005;7:662-70. https://doi.org/10.1016/j.ejheart.2005.01.014
  19. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9. https://doi.org/10.1161/01.CIR.0000116764.53225.A9
  20. Tavazzi L, Maggioni AP, Lucci D, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006; 27:1207-15.
  21. Kearney MT, Fox KA, Lee AJ, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002;40:1801-8. https://doi.org/10.1016/S0735-1097(02)02490-7
  22. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43: 635-41. https://doi.org/10.1016/j.jacc.2003.09.044
  23. Fonarow GC, Abraham WT, Albert NM, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008;168: 847-54. https://doi.org/10.1001/archinte.168.8.847
  24. Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, et al. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction: report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009;73:1893-900. https://doi.org/10.1253/circj.CJ-09-0254

Cited by

  1. Treatment Performance Measures Affect Clinical Outcomes in Patients With Acute Systolic Heart Failure vol.76, pp.5, 2011, https://doi.org/10.1253/circj.cj-11-1093
  2. Significance of Resting Heart Rate in Chronic Heart Failure: Data from Cardiac Insufficiency of Various Origin in Jeonbuk (CION-J) Registry vol.18, pp.1, 2011, https://doi.org/10.5646/jksh.2012.18.1.38
  3. Incremental Predictive Value of Red Cell Distribution Width for 12-Month Clinical Outcome After Acute Myocardial Infarction : RDW in myocardial infarction vol.36, pp.6, 2013, https://doi.org/10.1002/clc.22114
  4. Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) : An Open-Label Observational Study vol.13, pp.1, 2011, https://doi.org/10.1007/s40256-013-0004-9
  5. QRS Prolongation in the Prediction of Clinical Cardiac Events in Patients with Acute Heart Failure: Analysis of Data from the Korean Acute Heart Failure Registry vol.125, pp.2, 2013, https://doi.org/10.1159/000348334
  6. Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) re vol.103, pp.12, 2011, https://doi.org/10.1007/s00392-014-0743-x
  7. Insuficiencia cardiaca terminal; último acto vol.21, pp.2, 2011, https://doi.org/10.1016/j.medipa.2012.09.006
  8. Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure vol.15, pp.None, 2015, https://doi.org/10.1186/s12872-015-0082-5
  9. Medical Treatment of Acute Decompensated Heart Failure Syndrome vol.88, pp.2, 2011, https://doi.org/10.3904/kjm.2015.88.2.121
  10. Factors Affecting Adherence to Self-care Behaviors among Outpatients with Heart Failure in Korea vol.27, pp.2, 2011, https://doi.org/10.7475/kjan.2015.27.2.242
  11. Clinical Implications of Functional Tricuspid Regurgitation and Optimal Surgical Timing vol.91, pp.2, 2011, https://doi.org/10.3904/kjm.2016.91.2.139
  12. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry vol.37, pp.41, 2011, https://doi.org/10.1093/eurheartj/ehw331
  13. Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry) vol.16, pp.None, 2011, https://doi.org/10.1186/s12872-016-0267-6
  14. Gender Difference in the Prognostic Value of N-Terminal Pro-B Type Natriuretic Peptide in Patients With Heart Failure ― A Report From the Korean Heart Failure Registry (KorHF) ― vol.81, pp.9, 2011, https://doi.org/10.1253/circj.cj-16-1345
  15. Relationship Between Serum Sodium Level Within the Low-Normal Range on Admission and Long-Term Clinical Outcomes in Patients with Acute Decompensated Heart Failure vol.59, pp.5, 2011, https://doi.org/10.1536/ihj.17-524
  16. Acute Heart Failure and Its Management vol.11, pp.1, 2011, https://doi.org/10.18700/jnc.180047
  17. Bio-width index: a novel biomarker for prognostication of long term outcomes in patients with anaemia and heart failure vol.73, pp.4, 2011, https://doi.org/10.1080/00015385.2017.1408890
  18. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced vol.20, pp.None, 2011, https://doi.org/10.1186/s12968-018-0466-7
  19. Sex Differences in Long-Term Clinical Outcomes in Patients Hospitalized for Acute Heart Failure: A Report from the Korean Heart Failure Registry vol.28, pp.12, 2011, https://doi.org/10.1089/jwh.2018.7404
  20. Gender difference in the impact of Ischaemic heart disease on heart failure vol.50, pp.5, 2011, https://doi.org/10.1111/eci.13232
  21. Artificial intelligence for the diagnosis of heart failure vol.3, pp.1, 2011, https://doi.org/10.1038/s41746-020-0261-3
  22. Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis vol.17, pp.None, 2011, https://doi.org/10.2147/tcrm.s340587
  23. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes vol.45, pp.2, 2021, https://doi.org/10.4093/dmj.2020.0282
  24. Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat vol.12, pp.1, 2021, https://doi.org/10.1186/s13287-021-02440-4